Omnicell Financial Statements From 2010 to 2026

OMCL Stock  USD 45.14  0.16  0.35%   
Omnicell's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Omnicell's valuation are provided below:
Gross Profit
516 M
Profit Margin
0.0169
Market Capitalization
2.1 B
Enterprise Value Revenue
1.7313
Revenue
1.2 B
There are over one hundred nineteen available trending fundamental ratios for Omnicell, which can be analyzed over time and compared to other ratios. We recommend to check out Omnicell's recent fundamental drivers against the all of the trends between 2010 and 2026.

Omnicell Total Revenue

1.34 Billion

Check Omnicell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnicell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 108.4 M, Interest Expense of 3.4 M or Selling General Administrative of 459.2 M, as well as many indicators such as Price To Sales Ratio of 2.02, Dividend Yield of 0.0 or PTB Ratio of 3.78. Omnicell financial statements analysis is a perfect complement when working with Omnicell Valuation or Volatility modules.
  
Build AI portfolio with Omnicell Stock
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.

Omnicell Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.6 B2.4 B1.3 B
Slightly volatile
Short and Long Term Debt Total251.3 M439.9 M316 M
Slightly volatile
Other Current Liabilities175.6 M167.3 M99.5 M
Slightly volatile
Total Current Liabilities719.3 M685 M312.2 M
Slightly volatile
Other Liabilities33.7 M53.1 M45.6 M
Slightly volatile
Property Plant And Equipment Net167 M159 M80.6 M
Slightly volatile
Current Deferred Revenue243.9 M232.3 M109 M
Slightly volatile
Accounts Payable62.5 M59.5 M38 M
Slightly volatile
Cash445.8 M424.6 M219.4 M
Slightly volatile
Non Current Assets Total1.6 B1.5 B779.2 M
Slightly volatile
Non Currrent Assets Other91.2 M86.9 M55.2 M
Slightly volatile
Cash And Short Term Investments460.9 M438.9 M225 M
Slightly volatile
Net Receivables309.6 M294.9 M174.8 M
Slightly volatile
Common Stock Total Equity47 K49.5 K735.1 K
Slightly volatile
Common Stock Shares Outstanding36.9 M53.2 M38.7 M
Slightly volatile
Liabilities And Stockholders Equity2.6 B2.4 B1.3 B
Slightly volatile
Non Current Liabilities Total340.5 M324.3 M244.1 M
Slightly volatile
Inventory54 M102 M74 M
Slightly volatile
Other Current Assets107.2 M102.1 M49.2 M
Slightly volatile
Other Stockholder Equity1.1 BB549.9 M
Slightly volatile
Total Liabilities1.1 BB556.3 M
Slightly volatile
Property Plant And Equipment Gross370.3 M352.7 M122.1 M
Slightly volatile
Total Current Assets984.7 M937.8 M529.3 M
Slightly volatile
Short Term Debt223.4 M212.8 M71.9 M
Slightly volatile
Common Stock48.7 K51.3 K735.5 K
Slightly volatile
Property Plant Equipment113.5 M108.1 M60.7 M
Slightly volatile
Other Assets167.8 M159.8 M92.1 M
Slightly volatile
Good Will887.2 M844.9 M414 M
Slightly volatile
Intangible Assets297.9 M283.7 M183.7 M
Slightly volatile
Capital Surpluse729.3 M1.2 B712 M
Slightly volatile
Non Current Liabilities Other7.9 M8.3 M19.7 M
Slightly volatile
Deferred Long Term Asset Charges8.9 M8.5 M7.4 M
Slightly volatile
Long Term Investments63.7 M60.7 M25.7 M
Slightly volatile
Long Term Debt Total684.1 M651.6 M362.9 M
Slightly volatile
Short and Long Term Debt188.7 M200.5 M172.9 M
Slightly volatile
Net Invested Capital1.3 B1.8 BB
Slightly volatile
Capital Stock59.1 K65.5 K53 K
Slightly volatile
Capital Lease Obligations38.1 M37.6 M53.4 M
Slightly volatile

Omnicell Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization108.4 M103.2 M56.9 M
Slightly volatile
Selling General Administrative459.2 M437.3 M277.3 M
Slightly volatile
Total Revenue1.3 B1.3 B778.1 M
Slightly volatile
Gross Profit568.7 M541.7 M359.6 M
Slightly volatile
Other Operating Expenses1.3 B1.3 B755.7 M
Slightly volatile
Research Development109.2 M104 M62.2 M
Slightly volatile
Cost Of Revenue774.3 M737.4 M418.5 M
Slightly volatile
Total Operating Expenses568.3 M541.3 M337.2 M
Slightly volatile
Net Income Applicable To Common Shares6.2 M6.5 M22.3 M
Very volatile
Selling And Marketing Expenses560 K630 K687.6 K
Slightly volatile
Interest Income6.7 M5.1 M4.5 M
Slightly volatile
Reconciled Depreciation83.7 M103.2 M68 M
Slightly volatile
Extraordinary Items16 M18 M19.7 M
Slightly volatile

Omnicell Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow604.9 M576.1 M229.8 M
Slightly volatile
Depreciation108.4 M103.2 M58.2 M
Slightly volatile
Capital Expenditures23.9 M41.9 M33 M
Slightly volatile
End Period Cash Flow481.3 M458.4 M229.1 M
Slightly volatile
Stock Based Compensation22.6 M45.2 M28.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.021.662.5803
Pretty Stable
Days Sales Outstanding60.3575.7375.829
Slightly volatile
Stock Based Compensation To Revenue0.0270.03180.0348
Slightly volatile
Capex To Depreciation0.440.470.7889
Slightly volatile
EV To Sales1.861.672.5372
Slightly volatile
Inventory Turnover4.416.515.1629
Pretty Stable
Days Of Inventory On Hand84.0258.0474.9528
Slightly volatile
Payables Turnover8.2611.1510.3515
Slightly volatile
Sales General And Administrative To Revenue0.290.330.3571
Slightly volatile
Research And Ddevelopement To Revenue0.09440.09350.0859
Pretty Stable
Capex To Revenue0.03270.02950.047
Very volatile
Cash Per Share7.837.465.4393
Slightly volatile
Days Payables Outstanding41.433.936.8632
Slightly volatile
Intangibles To Total Assets0.230.420.3834
Slightly volatile
Current Ratio2.631.572.1329
Pretty Stable
Receivables Turnover5.484.994.9395
Slightly volatile
Graham Number9.511.5713.5888
Slightly volatile
Capex Per Share0.50.710.8711
Slightly volatile
Revenue Per Share11.521.7419.5364
Pretty Stable
Interest Debt Per Share7.947.576.6987
Slightly volatile
Debt To Assets0.120.160.2228
Slightly volatile
Operating Cycle167155153
Pretty Stable
Days Of Payables Outstanding41.433.936.8632
Slightly volatile
Quick Ratio2.31.41.8158
Pretty Stable
Cash Ratio1.230.710.8926
Pretty Stable
Cash Conversion Cycle126121116
Slightly volatile
Days Of Inventory Outstanding84.0258.0474.9528
Slightly volatile
Days Of Sales Outstanding60.3575.7375.829
Slightly volatile
Fixed Asset Turnover16.529.2511.838
Slightly volatile
Debt Ratio0.120.160.2228
Slightly volatile
Price Sales Ratio2.021.662.5803
Pretty Stable
Asset Turnover0.910.60.729
Slightly volatile
Gross Profit Margin0.570.490.4981
Slightly volatile

Omnicell Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.6 B1.8 BB
Slightly volatile
Enterprise Value1.7 B1.9 BB
Slightly volatile

Omnicell Fundamental Market Drivers

Forward Price Earnings29.4985
Cash And Short Term Investments381.7 M

Omnicell Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Omnicell Financial Statements

Omnicell investors utilize fundamental indicators, such as revenue or net income, to predict how Omnicell Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue232.3 M243.9 M
Total Revenue1.3 B1.3 B
Cost Of Revenue737.4 M774.3 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 0.33  0.29 
Research And Ddevelopement To Revenue 0.09  0.09 
Capex To Revenue 0.03  0.03 
Revenue Per Share 21.74  11.50 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports:
Check out the analysis of Omnicell Correlation against competitors.
For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.36)
Earnings Share
0.43
Revenue Per Share
25.429
Quarterly Revenue Growth
0.1
Return On Assets
0.0054
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.